Indie Asset Partners’s CVS Health CVS Stock Holding History

Indie Asset Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,977	Closed	-$221K	–	83
2023 Q1	$221K	Sell	2,977 -298	-9%	-$25K	0.26%	67
2022 Q4	$305K	Buy	3,275 +1	+0%	+$96	0.33%	57
2022 Q3	$312K	Hold	3,274	–	–	0.32%	57
2022 Q2	$303K	Hold	3,274	–	–	0.27%	66
2022 Q1	$331K	Sell	3,274 -85	-3%	-$8.93K	0.25%	73
2021 Q4	$347K	Buy	3,359 +50	+2%	+$4.62K	0.25%	84
2021 Q3	$281K	Buy	3,309 +1	+0%	+$84	0.23%	94
2021 Q2	$276K	Buy	3,308 +70	+2%	+$5.73K	0.22%	91
2021 Q1	$244K	Buy	3,238 +170	+6%	+$12.4K	0.28%	99
2020 Q4	$210K	Buy	+3,068	New	+$200K	0.24%	102
2020 Q3	–	Sell	-3,068	Closed	-$202K	–	95
2020 Q2	$202K	Buy	+3,068	New	+$193K	0.25%	90
2020 Q1	–	Sell	-3,415	Closed	-$254K	–	86
2019 Q4	$254K	Buy	+3,415	New	+$240K	0.27%	71

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Indie Asset Partners's CVS Position: Q2 2023 in Review

Indie Asset Partners sold out of CVS Health (CVS) in Q2 2023, closing a stake of 2,977 shares — an estimated $221K sold.

Indie Asset Partners first reported a position in CVS in Q4 2019 and held it in 12 quarters. The position peaked at $347K in Q4 2021. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

Indie Asset Partners reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
Indie Asset Partners sold 2,977 CVS Health shares in Q2 2023, an estimated $221K.
Indie Asset Partners first reported a position in CVS Health in Q4 2019 and held it in 12 quarters.
Indie Asset Partners's CVS Health position peaked at $347K in Q4 2021.
2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Indie Asset Partners's 13F filing for Q2 2023, filed 7 Aug 2023.